Literature DB >> 19587352

Anti-CTLA4 antibody-induced lupus nephritis.

Fouad Fadel, Khalil El Karoui, Bertrand Knebelmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19587352     DOI： 10.1056/NEJMc0904283

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  107 in total

Review 1.  Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma.

Authors:  Xiang-Yang Wang; Daming Zuo; Devanand Sarkar; Paul B Fisher
Journal:  Expert Opin Pharmacother       Date:  2011-12       Impact factor: 3.889

2.  Kidney injuries related to ipilimumab.

Authors:  Hassane Izzedine; Victor Gueutin; Chems Gharbi; Christine Mateus; Caroline Robert; Emilie Routier; Marina Thomas; Alain Baumelou; Philippe Rouvier
Journal:  Invest New Drugs       Date:  2014-04-01       Impact factor: 3.850

Review 3.  Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future.

Authors:  Mark A Perazella; Anushree C Shirali
Journal:  J Am Soc Nephrol       Date:  2018-06-29       Impact factor: 10.121

Review 4.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

Review 5.  Immunomodulatory therapy for melanoma: ipilimumab and beyond.

Authors:  Margaret K Callahan; Michael A Postow; Jedd D Wolchok
Journal:  Clin Dermatol       Date:  2013 Mar-Apr       Impact factor: 3.541

6.  Novel immune checkpoint blocker approved for the treatment of advanced melanoma.

Authors:  Lorenzo Galluzzi; Guido Kroemer; Alexander Eggermont
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

Review 7.  Adverse events associated with immune checkpoint inhibitor treatment for cancer.

Authors:  Khashayar Esfahani; Nicholas Meti; Wilson H Miller; Marie Hudson
Journal:  CMAJ       Date:  2019-01-14       Impact factor: 8.262

Review 8.  Renal complications of immune checkpoint blockade.

Authors:  Naoka Murakami; Shveta Motwani; Leonardo V Riella
Journal:  Curr Probl Cancer       Date:  2016-12-19       Impact factor: 3.187

9.  Endocrine-Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management.

Authors:  Jaydira Del Rivero; Lisa M Cordes; Joanna Klubo-Gwiezdzinska; Ravi A Madan; Lynnette K Nieman; James L Gulley
Journal:  Oncologist       Date:  2019-10-10

10.  Inhibition of melanoma growth by subcutaneous administration of hTERTC27 viral cocktail in C57BL/6 mice.

Authors:  Longfei Huo; Hong Yao; Xicai Wang; Gee Wan Wong; Hsiang-fu Kung; Marie C Lin
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.